Recruiting Heart Attack Studies in Redlands
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients....
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
This purpose of this study is to establish proof of concept of tebapivat in participants with LR-MDS in Phase 2a and to evaluate the effect of tebapivat on transfusion independence (TI) in participant...
About Heart Attack Clinical Trials in Redlands
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Redlands, CA. These studies are seeking a combined 302 participants. Research is being sponsored by Italfarmaco, Agios Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Redlands — FAQ
Are there heart attack clinical trials in Redlands?
Yes, there are 2 heart attack clinical trials currently recruiting in Redlands, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Redlands?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Redlands research site will contact you about next steps.
Are clinical trials in Redlands free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Redlands studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Redlands are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov